Recruiting now—Ages 7 Years to 29 Years
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Sponsor: Rigshospitalet, Denmark · NCT05840575 on ClinicalTrials.gov ↗
Conditions studied
Chemotherapy-Related Cognitive ImpairmentChemotherapeutic ToxicityChemo-brainCancerChildhood CancerHodgkin LymphomaNon Hodgkin LymphomaTesticular CancerSarcomaLeukemia
Where it's running1 site
1 international site
- Recruiting now
Rigshospitalet
Copenhagen, Denmark 2100
- Lisa L Hjalgrim, PhD, MD(contact)+4535450962[email protected]
- Barbara JT Nordhjem, PhD(contact)+4535457998[email protected]
- Lisa L Hjalgrim, PhD, MD(principal investigator)
- Barbara JT Nordhjem, PhD(sub investigator)
- Helle Pappot, Professor, MD(sub investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Patients who are newly diagnosed with a non-CNS cancer and will undergo chemotherapy at University Hospital Copenhagen, Rigshospitalet. * At the age of 7-29 years at diagnosis * Each patient is matched (1:1) with a control participant within 24 months of age. The controls are recruited from the patient's own social circle and can be a friend, partner, or close family (sibling or cousin). Exclusion Criteria: * Unable to speak and understand Danish * Severe intellectual disability or mental health disorder that hinders participation * Brain metastases, * Terminal illness * Have had a previous chemotherapy or radiotherapy treatment
Updated 2023-05-03 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.